‘Next generation’ treatment to cure leukaemia given NHS approval

Family handout/NHS England

By Jane Kirby, PA Media

A “next generation” immunotherapy treatment that has the potential to cure leukaemia has been given NHS approval.

Obe-cel is a type of CAR T-cell therapy developed in the UK and works by genetically modifying cells to enable the body’s own immune system to recognise and attack cancer.